250
Participants
Start Date
Not specified
Study Completion Date
February 29, 1996
Bleomycin sulfate
Vincristine sulfate
Doxorubicin hydrochloride
Cyclophosphamide
Allopurinol
Methotrexate
Cytarabine
Leucovorin calcium
Sargramostim
Dexamethasone
NY Univ. HIV/AIDS CRS, New York
Memorial Sloan-Kettering Cancer Ctr., New York
SUNY - Buffalo, Erie County Medical Ctr., Buffalo
Univ. of Rochester ACTG CRS, Rochester
Pitt CRS, Pittsburgh
Hosp. of the Univ. of Pennsylvania CRS, Philadelphia
Northwestern University CRS, Chicago
Rush Univ. Med. Ctr. ACTG CRS, Chicago
University of Colorado Hospital CRS, Aurora
UCLA CARE Center CRS, Los Angeles
Unc Aids Crs, Chapel Hill
The Ohio State Univ. AIDS CRS, Columbus
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
USC CRS, Los Angeles
Ucsf Aids Crs, San Francisco
Johns Hopkins Adult AIDS CRS, Baltimore
Bmc Actg Crs, Boston
Washington U CRS, St Louis
Case CRS, Cleveland
Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston
Beth Israel Deaconess - East Campus A0102 CRS, Boston
Beth Israel Med. Ctr. (Mt. Sinai), New York
Collaborators (1)
Schering-Plough
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH